// App-Quantinova.ai

3072 : Combination of ibrutinib and corticosteroids in B-cell non-Hodgkin lymphomas (NHL)

Researchers

Presenter

  • Hsu-Ping Kuo

Principal Investigators

  • Sidney Hsieh

  • Karl J. Schweighofer

  • Leo WK Cheung

  • Mutiah Apatira

  • Mint Sirisawad

  • Shiquan Wu

  • Karl Eckert

  • Yu Liang

  • Jeff Hsu

  • Chun-Te Chen

  • Darrin Beaupre

  • Betty Y. Chang

Medical Centers

  • Pharmcyclics LLC, an AbbVie Company, Sunnyvale, CA

Locations

  • United States

Companies

  • Pharmacyclics LLC

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved